Praxis Precision Medicines, Inc.

NASDAQ:PRAX

Biotechnology

Healthcare
$310.90 +4.49%

+$12.13 today

Market cap
$8.69B
Beta
2.75
P/E (TTM)
-25.0
EPS (TTM)
-$11.31
52W Low $37.19High $366.52

Volume 0.63M

Average 0.45M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$249.07M

FY 2025 · Annual

Investing Cash Flow

-$311.15M

FY 2025 · Annual

Financing Cash Flow

$702.17M

FY 2025 · Annual

+36.5% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(167.06M)(214.03M)(123.28M)(182.82M)(303.27M)
Depreciation & Amortization182K419K432K358K140K
Deferred Income Tax2.09M0000
Stock-Based Compensation22.69M28.59M24.86M41.36M33.94M
Change in Working Capital16.13M(1.78M)(13.03M)10.92M22.68M
Accounts Receivables00000
Inventory00000
Accounts Payables7.27M3.89M(8.86M)6.71M12.1M
Other Working Capital8.87M(5.67M)(4.17M)4.21M10.58M
Other Non-Cash Items1.41M1.76M(121K)(1.58M)(2.56M)
Operating Cash Flow(124.55M)(185.04M)(111.14M)(131.76M)(249.07M)
Capital Expenditures(1.05M)(444K)(50K)0(56K)
Acquisitions (Net)139.47M(97.33M)000
Purchases of Investments(164.17M)(83.02M)0(371.52M)(623.81M)
Sales of Investments24.7M180.36M39M123.03M312.72M
Other Investing Activities(139.47M)97.33M000
Investing Cash Flow(140.52M)96.89M38.95M(248.49M)(311.15M)
Debt Repayment(763K)0000
Common Stock Issued105.71M9.56M91.59M512M704.26M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.64M904K279K2.33M(2.09M)
Financing Cash Flow107.59M10.47M91.87M514.32M702.17M
Effect of Forex Changes00000
Net Change in Cash(157.49M)(77.69M)19.69M134.07M141.96M
Free Cash Flow(125.6M)(185.49M)(111.19M)(131.76M)(249.12M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$303.3M
+ D&A$140.0K
+ Stock-Based Comp$33.9M
+ Deferred Tax$0
+ Working Capital$22.7M
- Other Non-Cash-$2.6M
= Operating Cash Flow-$249.1M
- Capex-$56.0K
= Free Cash Flow-$249.1M

Analysis

FY2025 free cash flow is -$249.1M. FCF conversion is 82.1% of net income. Operating cash flow was -$249.1M, with capex of -$56.0K. The largest bridge item is Stock-Based Comp at $33.9M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

Does PRAX generate free cash flow?

Praxis Precision Medicines, Inc. (PRAX) generated -$249.12M of free cash flow in fiscal 2025.

How much operating cash flow does PRAX produce?

Operating cash flow was -$249.07M, before capital expenditures of $56,000.00.